Biognosys

🍁Biognosys at #HUPO2025🍁

📍 Visit booth #803, join our breakfast seminar, or drop by our posters. We'd love to connect and explore how we can help you advance your research. 🔬

Learn more: biognosys.com/conferences/...

See you in Toronto!

#Proteomics #Spectronaut

Meet us at Discovery & Development 2025 in San Diego!💊🔬

Stop by Booth #26 to meet the team and explore how our #proteomics services can accelerate your discovery programs.

We look forward to connecting with you!

#DiscoveryDevelopment25 #OGDiscovery #DiscoveryUS25

Fall Proteomics Social Join us for an engaging evening of networking and science on October 9 in Boston, MA!

📢 Only a few days left until our Fall Proteomics Social in Boston!🍂 Join us to network and learn how next-generation #proteomics can answer your research questions.

Save your spot here👉 biognosys.com/conferences/...

#Biomarkers #DrugDiscovery #DrugDevelopment

We're on site at Biomarkers & Precision Medicine by Oxford Global in London!🧪

Come visit us at booth #43 and learn about how we are advancing #PrecisionMedicine with next-generation #proteomics. Let's connect and discuss how we can support your research.🤝

#OGPREMED

🚀Expanding the #multiomics horizon at Biognosys!

We are happy to announce expansion of our CRO services to include quantitative #metabolomics and #lipidomics, perfectly complementing our world-class #proteomics services.

👉 Learn more: biognosys.com/news/biognos...

#DrugDiscovery

Fall Proteomics Social Join us for an engaging evening of networking and science on October 9 in Boston, MA!

Join our Fall Proteomics Social in Boston!🍂

Whether you're already working in #proteomics or are simply interested in how it is reshaping the future of #DrugDiscovery and development — make sure not to miss this event!

🔗 Learn more and register: biognosys.com/conferences/...

We are excited to be part of Biomarkers & Precision Medicine 2025!🔬

Meet us at booth #43 and visit our talk "Use of Mass-spec Based Proteomics for Biomarker Discovery in Clinical Plasma and Tissue Samples".

Learn more: oxfordglobal.com/precision-me...

#PrecisionMedicine #OGPREMED

Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research New biocrates metabolomics/lipidomics offering enhances Biognosys’ proteomics capabilities to support multiomic drug discovery and clinical/translational research

📢We're expanding our CRO services to include quantitative #metabolomics and #lipidomics, powered by biocrates' MxP® Quant 1000 kit and Bruker EVOQ® mass spectrometry.

👉Discover how we're driving #PrecisionMedicine forward with comprehensive #multiomics: biognosys.com/news/biognos...

Unlock deeper insights into Targeted Protein Degradation!
In this seminar, Eric Kuhn, Associate Director at Kymera Therapeutics, presents how our #TargetedProteomics services enabled quantification of IRAK4 degradation in PBMC samples from a Phase 1 trial.
👉 biognosys.com/resources/ma...

☕Last week we had the pleasure of attending Paris Saclay Cancer Cluster's ecosystem breakfast where we presented how next-generation #proteomics can be applied to study mechanisms of immune resistance.

👉Watch the replay: www.parissaclaycancercluster.org/post/next-ge...
#oncology #BiomarkerDiscovery

We're attending Discovery & Development US 2025! Meet our team at Booth #26 and visit our poster "Drug target ID and binding site mapping in complex cellular environments using LiP-MS".

🔗Learn more: oxfordglobal.com/discovery-de...

#OGDiscovery #DiscoveryUS25 #proteomics #DrugDiscovery

Precision Meets Depth: Proteomic Solutions for Hard-to-Measure Targets SISCAPA and Biognosys: A Unified Workflow for Accurate Quantitation of Challenging Proteins

Through our partnership with SISCAPA Assay Technologies, Biognosys offers an end-to-end solution for mass spectrometry driven ultra-sensitive, protein quantification across plasma, CSF, serum, dried blood spots, and tissue lysates.

📄 Learn more 👉 biognosys.com/resources/pr...

#TargetedProteomics

Increasing the identification of ERAP1 inhibitor dependent antigens with Spectronaut 20 In Part 2 of our Spectronaut 20 series, Dan Green (Greywolf Therapeutics) demonstrates how new advances in Spectronaut 20 expand the ERAP1 inhibitor antigen landscape.

In Part 2 of our #Spectronaut 20 series, Daniel Green from Greywolf Therapeutics demonstrates how new advances in Spectronaut expand the ERAP1 inhibitor antigen landscape—delivering 47% more peptide discoveries with #directDIA.

Watch the seminar recording: biognosys.com/resources/in...

Thank you for joining us at the 15th International Symposium on #Proteomics in the Life Sciences! Whether you stopped by our booth or joined our presentation, we truly appreciate your interest and engagement. 🙌

Learn more about #Spectronaut 20: biognosys.com/resources/as...

🔬 Simplify your #PTM analysis with #Spectronaut® 20!

Our #ASMS poster shows how automation boosts PTM workflows with:

⚙️ Automated input normalization
📈 3–6x more stoichiometry values
✅ Simple, reproducible results

📥 Download the poster: biognosys.com/resources/a-...

🚨 New preprint alert!

@pranvera.bsky.social uses single-cell proteomics + #Spectronaut® to decode neutrophil roles in glioblastoma.

1,100 proteins from single cells—revealing dynamic states in brain cancer.

🔬 Read more: www.biorxiv.org/content/10.1...

Biognosys is proud to sponsor the 15th International Symposium on Proteomics in the Life Sciences hosted by @asbmb.bsky.social! 🎉

Visit our booth to explore our cutting-edge #DIA, #DDA, and targeted software solutions, and learn about our latest #immunopeptidomics work powered by #Spectronaut® 20.

#Spectronaut® has used AI for #DIA since day one—Spectronaut 20 takes it even further for #immunopeptidomics.

Our recent poster breaks down how our AI models evolved to boost peptide ID power with clear, stepwise improvements.

🧠 Check it out👉 biognosys.com/resources/op...

⛰️📈 Brixen Proteomics Summer School never disappoints!

A big thank you to everyone who joined our #Spectronaut workshops and brought their insightful questions, energy, and enthusiasm.

See you next time — and until then, let’s keep pushing the boundaries of #proteomics!👋💪

🎯 Discover how #Spectronaut® 20 improves peak picking, reduces background noise, and minimizes interference resulting in significantly enhanced quant accuracy.

📊 Check out our poster for a deep dive into the algorithmic upgrades driving these results👉 biognosys.com/resources/ha...

Let’s talk #AlzheimersResearch — come visit us at #AAIC25 in Toronto!🧠

Meet the Biognosys team at Booth #1620 to explore how next-gen #proteomics is accelerating #neuroscience.

Learn more: biognosys.com/conferences/...

#BiomarkerDiscovery #MassSpectrometry #Neurodegeneration

🚀Kuiper in #Spectronaut ®20 delivers >70% more unspecific peptide IDs (including HLA I & II) in a fraction of the time, no library needed!

⚡Ditch outdated workflows: see our poster to break free from slow, library‑based searches👇 biognosys.com/resources/in...

#DIA #directDIA #MassSpectrometry

Biognosys is now the preferred service provider for SISCAPA Assay Technologies, delivering their advanced immuno-enrichment technology to our customers.

📥Read our app note to discover how SISCAPA powers targeted proteomics for hard-to-measure proteins: biognosys.com/resources/pr...

💡 At #ASMS2025, Daniel Green from Greywolf Therapeutics shared how they applied Biognosys' #Immunopeptidomics CRO Services to support their ERAP-1 inhibitor program—profiling PBMC samples with our optimized DIA-MS workflow.

🎥 Watch here: biognosys.com/resources/qu...

#Proteomics #Pharmacodynamics

📢 Catch Biognosys at #Brixen #Proteomics Summer School, July 27–Aug 2! Chris Below dives into diagonal PASEF for peptide IDs, and Monika Puchalska leads #DIA workshops with #Spectronaut20.

Learn more: www.brixenproteomics.org

Missed our seminar at #ASMS2025? Watch the recording to discover how Biognosys, in collaboration with Johns Hopkins University (@jhu.edu), is driving early detection of neurodegenerative diseases with advanced #proteomics contract research services.

🎥 Watch now: biognosys.com/resources/ci...

Unlocking the Immunopeptidome: Advancing Drug Development Through Cutting-Edge Mass Spectrometry

With unmatched sensitivity and reproducibility, our services empower researchers to decode the #immunopeptidome with confidence — enabling personalized immunotherapies, vaccine development, and precision #ImmunoOncology.

👉 Download the white paper to learn more: biognosys.com/resources/un...

Meet us next week at #AAIC25 in Toronto!

Visit Booth #1620 to learn how #proteomics can power your #AlzheimersResearch and see our poster ''Early Detection of Molecular Signatures in Amyloid Conversion and Cognitive Decline through P2 Plasma Proteomics''.

Learn more: biognosys.com/conferences/...

🚀 #Spectronaut 20 + the Kuiper engine push #DIA to new heights!
🎥 In this seminar, we break down how they transform #immunopeptidomics & unspecific workflows.

📈75% more HLA-I IDs
⚡70% faster
🔎New PTM Probing

👉 Watch now: biognosys.com/resources/as...

#proteomics

New App Note: Unlock Precision with TrueSignature Targeted Proteomics!

Featuring a PBMC case study, highlighting the robust performance of the workflow in a complex matrix of primary immune cells, with accurate quantification of targeted protein panels.

Download👉 biognosys.com/resources/ab...